Latest News and Press Releases

Results from the study underpin the potential of Purespring’s lead AAV gene therapy programme, PS-002, as an important novel modality to treat IgAN Data support progression towards a Phase I/II...

Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases Oversubscribed financing led by Sofinnova Partners in collaboration with Gilde...

Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases Oversubscribed financing led by Sofinnova Partners in collaboration with Gilde...

Purespring Therapeutics presents preclinical data at the 61st ERA Congress Data establishes the potential of AAV gene therapy to deliver transgenes to the podocyte to replace defective genes or to...

Purespring appoints Fredrik Erlandsson as Chief Medical Officer and Peter Mulcahy as Chief People Officer Appointments of Fredrik and Peter complete build-out of senior team London— 6 September...

Senior leadership team strengthened as Purespring prepares kidney gene therapy programmes for clinical development London— 2 August 2023— Purespring Therapeutics, the pioneering gene therapy...

Purespring Therapeutics strengthens scientific leadership with the appointment of Alice Brown as Chief Scientific Officer London— 07 September 2022— Purespring Therapeutics, a pioneering gene therapy...

Purespring Therapeutics strengthens scientific leadership with the appointment of Alice Brown as Chief Scientific Officer London— 07 September 2022— Purespring Therapeutics, a pioneering gene therapy...

Purespring Therapeutics Expands Senior Team with Key Appointments Appointments include Dr Pille Harrison as VP of Clinical Development, Dr Aoife Waters as Medical Director, Nick Cetateanu as Head of...

Purespring Therapeutics and SwanBio Therapeutics announce licensing agreement for use of FunSel screening platform FunSel is Purespring’s proprietary in-vivo ‘gene search engine’, which allows...